Article

Early identification of suboptimal responders to metformin in type 2 diabetes using long-term real-world HbA1c trajectories

2026-07-20

Abstract excerpt

<h4>Aims</h4> Metformin remains the primary treatment for type 2 diabetes, yet over 40% of patients fail to maintain glycaemic control. We aimed to identify patients unlikely to respond to metformin prior to treatment initiation and to evaluate whether on-treatment management can improve glycaemic outcomes in suboptimal responders, informing early treatment decisions. <h4>Materials and Methods</h4> We analyzed 5...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 53c04d80-b65b-531c-8401-b8a86552a7de
DOI: 10.64898/2026.07.17.26357984

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Early identification of suboptimal responders to metformin in type 2 diabetes using long-term real-world HbA1c trajectoriesDOI 10.64898/2026.07.17.26357984Read

Derivation and validation of a type 2 diabetes treatment selection algorithm for SGLT2-inhibitor and DPP4-inhibitor therapies based on glucose-lowering efficacy: cohort study using trial and routine clinical dataSemantic proximity Read

Metformin Pharmacogenomics: Current Status and Future DirectionsSemantic proximity Read

GLP1R Variants and Polygenic Risk Underlie Heterogeneous Response to GLP-1 Receptor Agonists in Type 2 DiabetesSemantic proximity Read

Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulinSemantic proximity Read

Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics.Semantic proximity Read

A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin.Semantic proximity Read

Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.Semantic proximity Read

Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.Semantic proximity Read

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.Semantic proximity Read

Variants in<i>STAU2</i>associate with metformin response in a type 2 diabetes cohort: a pharmacogenomics study using real-world electronic health record dataSemantic proximity Read

Using joint models to adjust for informative drop-out when modelling a longitudinal biomarker: an application to type 2 diabetes disease progressionSemantic proximity Read

Estimating Heritability of Glycaemic Response to Metformin using Nationwide Electronic Health Records and Population-Sized PedigreeSemantic proximity Read